Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarah London
Payers
Margin improvements key to Centene's 2027 ACA plan strategy: CEO
Centene reported $1.1 billion in profit for the second quarter of 2026, rebounding from a loss a year ago.
Paige Minemyer
Jul 28, 2026 1:30pm
Centene's stock falls as CEO outlines ongoing ACA headwinds
Mar 10, 2026 11:52am
Centene putting focus on Medicaid improvements, CEO London says
Feb 6, 2026 12:30pm
Centene reaffirms commitment to ACA market amid turbulence
Oct 29, 2025 12:00pm
HLTH25: Marketplace payers still bullish on ICHRA's potential
Oct 22, 2025 2:01pm
Centene slashes 2025 guidance amid ACA marketplace headwinds
Jul 25, 2025 12:00pm
